Sacituzumab govitecan | 台灣精品獎-歷屆得獎名單
2021年4月7日—FDAgrantedregularapprovaltosacituzumabgovitecan(Trodelvy,ImmunomedicsInc.)forpatientswithunresectablelocallyadvancedor ...,Sacituzumabgovitecan,soldunderthebrandnameTrodelvy,isaTrop-2-directedantibodyandtopoisomeraseinhibitordrugconjugateusedforthetreatment ...,由LACarey著作·2022·被引用1次—Sacituzumabgovitecan(SG)isanantibody-drugconjugate(ADC)composedofahumanizedtrophoblastcell-surfaceantigen-2(Trop-2)antibody ...,由ABardia著作·2021·被引用208次—Sacituzumabgovitecanisanantibody-...
sacituzumab govitecan台灣 sacituzumab govitecan中文 Sacituzumab govitecan in metastatic triple-negative breast cancer Sacituzumab govitecan FDA Pembrolizumab sacituzumab govitecan Sacituzumab Trodelvy Sacituzumab govitecan trop2 Sacituzumab govitecan Sacituzumab pembrolizumab Pembrolizumab sacituzumab govitecan Gs U.S. 592 6173 Trodelvy NSCLC Nct02574455 TROPHY u 01 IMMU-132 sacituzumab govitecan台灣 sacituzumab govitecan中文 Trodelvy Sacituzumab govitecan in metastatic triple-negative breast cancer Sacituzumab govitecan trop2 TRODELVY label Sacituzumab govitecan-hziy FDA Enfortumab vedotin Sacituzumab govitecan earns full approval for triple negative breast cancer Sacituzumab govitecan FDA sacituzumab govitecan-hziy in refractory metastatic triple-negative breast cancer Trastuzumab deruxtecan Nejm breast cancer Sacituzumab govitecan resistance sacituzumab govitecan-hziy TROPiCS-02 trodelvy台灣 trodelvy中文 三陰 新藥 高惡性乳癌 白金 乳癌 乳癌 化療 抗 藥性 雲頂新耀台灣 雲頂新耀有限公司 三陰性乳癌 新藥 藥物試驗 打工 trodelvy香港 trodelvy仿單 Trodelvy price 浴室 加 裝 暖 風機 Tokuyo 玩 美 椅 tc 730 轉角氣缸 升望科技股份有限公司ptt mx34vq規格 new reach furniture co op pringo維修 d-link dhp-600av
FDA grants regular approval to sacituzumab govitecan for ... | 台灣精品獎-歷屆得獎名單
2021年4月7日 — FDA granted regular approval to sacituzumab govitecan (Trodelvy, Immunomedics Inc.) for patients with unresectable locally advanced or ... Read More
Sacituzumab govitecan | 台灣精品獎-歷屆得獎名單
Sacituzumab govitecan, sold under the brand name Trodelvy, is a Trop-2-directed antibody and topoisomerase inhibitor drug conjugate used for the treatment ... Read More
Sacituzumab govitecan as second | 台灣精品獎-歷屆得獎名單
由 LA Carey 著作 · 2022 · 被引用 1 次 — Sacituzumab govitecan (SG) is an antibody-drug conjugate (ADC) composed of a humanized trophoblast cell-surface antigen-2 (Trop-2) antibody ... Read More
Sacituzumab Govitecan in Metastatic Triple ... | 台灣精品獎-歷屆得獎名單
由 A Bardia 著作 · 2021 · 被引用 208 次 — Sacituzumab govitecan is an antibody-drug conjugate composed of an antibody targeting the human trophoblast cell-surface antigen 2 (Trop-2), ... Read More
Sacituzumab Govitecan in Metastatic Triple | 台灣精品獎-歷屆得獎名單
由 A Bardia 著作 · 2021 · 被引用 206 次 — Sacituzumab govitecan is an antibody–drug conjugate composed of an antibody targeting the human trophoblast cell-surface antigen 2 (Trop-2), ... Read More
Sacituzumab Govitecan | 台灣精品獎-歷屆得獎名單
2022年2月1日 — Sacituzumab govitecan-hziy injection is used to treat triple-negative breast cancer that has spread (metastatic) or cannot be removed by ... Read More
Trial of Sacituzumab Govitecan in Participants With Refractory ... | 台灣精品獎-歷屆得獎名單
Participants will receive sacituzumab govitecan on Days 1 and 8 of a 21-day treatment cycle for up to 29.6 months. Participants will continue treatment until ... Read More
Trodelvy - European Medicines Agency | 台灣精品獎-歷屆得獎名單
sacituzumab govitecan. Therapeutic area (MeSH). Breast Neoplasms; Triple Negative Breast Neoplasms. Anatomical therapeutic chemical (ATC) code. Read More
相關資訊整理
103 年度台灣精品獎獲獎產品 LifeHub - 延長型 USB 電源分享器
由「台達電子工業股份有限公司」生產的LifeHub-延長型USB電源分享器獲得103年度台灣精品獎,以下為此獎項詳細資料整理:得獎...